Andrew Morris

UAMS Mourns Loss of Susan Smyth, M.D., Ph.D.

By Yavonda Chase

Susan Smyth, M.D., discusses cardiology cases with clinical team members. (From left) Divya Nayar, M.D., neurology resident; Abdallah Malkawi, M.D., cardiovascular medicine fellow; and Tushar Tarun, M.D., assistant professor, cardiovascular medicine.Bryan Clifton

LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) is sad to announce that Susan Smyth, M.D., Ph.D. executive vice chancellor and dean of the College of Medicine, died on Dec. 31, 2022, after a battle with cancer.

“Susan was a remarkable leader, colleague, and friend who will be deeply missed by many across our state, especially those of us fortunate enough to work with her,” wrote Chancellor Cam Patterson, M.D., MBA, in an announcement to UAMS employees and students. “Her death is a great loss for UAMS, our state, and all who knew her.”

She is survived by her husband, Andrew Morris, Ph.D., professor in the UAMS Department of Pharmacology and Toxicology, and their sons, Edward and William.

https://news.uams.edu/2023/01/03/uams-mourns-loss-of-susan-smyth-m-d-ph-d/

UAMS Invests Andrew J. Morris, Ph.D., in Mehta/Stebbins Chair in Cardiovascular Research

By Andrew Vogler

The University of Arkansas for Medical Sciences (UAMS) College of Medicine invested Andrew J. Morris, Ph.D., professor in the Department of Pharmacology and Toxicology, in the Mehta/Stebbins Chair in Cardiovascular Research during a Nov. 9 ceremony.

“I am honored to have this chair, and as I learn more about UAMS, I am grateful for the opportunity to be part of its community and to contribute to its history,” said Morris. “I’ve been an independent researcher for almost 30 years, and I am lucky in that I’ve had a very rewarding career.”

Morris also serves as a research investigator at the Central Arkansas Veterans Healthcare System. His work is related to understanding interactions between genetic, behavioral and environmental risk factors for non-communicable diseases using multidisciplinary approaches that combine biochemical, molecular genetic and cell biological methods with preclinical models and population health studies.